Fundraising FoxSonivate Medical
Portland, US · Oregon corporation
Find your way into Sonivate Medical
Sign up to see every warm intro you have to Sonivate Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sonivate Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sonivate Medical develops ultrasound-based medical devices, drawing on expertise in cardiac ultrasound and medical device engineering. The company is based in Portland, Oregon.
Founders & leadership
RW
Ronald W. SchutzCMO | Founder/Director | Chairman Emeritus
DG
David G. StarrCo-founder
BM
Bernard M. MaraVice President of Engineering
EJ
Elizabeth J. EttlingExecutive
SS
Scott S. CorbettChief Technology Officer2007–2018Scott Corbett has four decades of experience in biomedical engineering, including senior executive roles at early-stage companies and co-founding multiple medical device firms in the Seattle and Portland area; his technical background spans acoustics, medical ultrasound, sensors, and electrical-mechanical packaging, with over 20 patents in medical devices and related fields.
DK
Drew KnowlesNamed on SEC filing
RD
Robert Dufresne, Jr.Named on SEC filing
JW
Jason WanderseeNamed on SEC filing
RS
Ronald Schutz, MDNamed on SEC filing
Board
CG
Carl G. Anderson, Jr.Chairman of the Board
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 2 of 3 rounds · 2014–2019
▶$2.8MraisedNov 2019 · 18 investors · Other Health CareRule 506(b)
▶$2.8MraisedNov 2019 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James HatlanExecutive Officer, Director, Promoter
- Carl Anderson, Jr.Director
- Drew KnowlesDirector
- Robert Dufresne, Jr.Director
- Jason WanderseeDirector
- Ronald Schutz, MDDirector
- Offering amount
- $3M
- Amount sold
- $2.8M
- First sale
- Nov 2017
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
▶$540KraisedAug 2014 · 5 investors · Other Health CareRule 506(b)
▶$540KraisedAug 2014 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth J. EttlingExecutive Officer
- Carl G. Anderson, Jr.Director
- Ronald W. SchutzDirector
- Scott S. CorbettExecutive Officer
- Robert S. Dufresne, Jr.Director
- Jason WanderseeDirector
- David G. StarrExecutive Officer, Director, Promoter
- Offering amount
- $1.6M
- Amount sold
- $540K
- First sale
- Apr 2014
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
SonovascularSonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.
Sonex HealthSonex Health develops ultrasound-guided medical devices for orthopedic conditions, including UltraGuideCTR, a device that enables carpal tunnel release to be performed in a clinic setting. The company targets physicians and healthcare providers seeking minimally invasive treatments with faster patient recovery.
Sonus MicrosystemsSonus Microsystems develops customizable ultrasound transducers designed to improve accessibility of medical diagnostics. The company serves medical device manufacturers and healthcare providers seeking advanced ultrasound technology.
Innova VascularInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
SonavexSonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.
Companies working in the same space as Sonivate Medical.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase I | 2023 | $74.9K |
| Department of DefenseDefense Health Program | Phase II | 2015 | $999.3K |
| Department of DefenseDefense Health Program | Phase I | 2014 | $149.8K |
| U.S. ArmyArmy | Phase II | 2010 | $1.2M |
| U.S. ArmyArmy | Phase I | 2010 | $118.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sonivate Medical do?
- Sonivate Medical develops ultrasound-based medical devices, drawing on expertise in cardiac ultrasound and medical device engineering. The company is based in Portland, Oregon.
- Who founded Sonivate Medical?
- Sonivate Medical was founded by Ronald W. Schutz, David G. Starr.
- How much funding has Sonivate Medical raised?
- Sonivate Medical has disclosed $3.3M raised across 2 of its 3 known rounds.
- Where is Sonivate Medical headquartered?
- Sonivate Medical is headquartered in Portland, US.